BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15132046)

  • 21. As the tide turns: the changing HIV/AIDS epidemic and the criminalization of HIV exposure.
    McArthur JB
    Cornell Law Rev; 2009 Mar; 94(3):707-42. PubMed ID: 19507336
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiretroviral therapy of acquired immunodeficiency syndrome (AIDS)].
    Jevtović Dj; Ranin J; Salemović D; Brmbolić B; Zerjav S
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():38-41. PubMed ID: 18170976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can responses to antiretroviral therapy be improved by therapeutic drug monitoring?
    Haas DW
    Clin Infect Dis; 2006 Apr; 42(8):1197-9. PubMed ID: 16575742
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV therapy--what's new?
    Chew GS
    N Z Med J; 1996 May; 109(1021):172. PubMed ID: 8657375
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent advances in antiretroviral drugs.
    Ghosh RK; Ghosh SM; Chawla S
    Expert Opin Pharmacother; 2011 Jan; 12(1):31-46. PubMed ID: 20698725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2004 antiretroviral drug guide.
    IAPAC Mon; 2004 Oct; 10 Suppl 1():8-35. PubMed ID: 15641182
    [No Abstract]   [Full Text] [Related]  

  • 27. [HIV infection, acquired immunodeficiency syndrome (AIDS)].
    Izumo S
    Nihon Rinsho; 2004 Jan; 62 Suppl():219-23. PubMed ID: 15011353
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for HIV Infection.
    Treat Guidel Med Lett; 2004 Jan; 2(17):1-8. PubMed ID: 15529108
    [No Abstract]   [Full Text] [Related]  

  • 29. [Development of new enzyme inhibitors for the treatment of AIDS[ ].
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1992; 54(2):139-53. PubMed ID: 1384252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance to anti-retroviral therapy in Chilean patients with HIV-1 from 2002 to 2005].
    Afani S A; Orellana R L; Duarte J P; Acevedo M W; Morales B O; Wolff R M; Vásquez P; Beltrán C
    Rev Med Chil; 2007 Oct; 135(10):1237-44. PubMed ID: 18180829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risks and incidence of K65R and L74V mutations and subsequent virologic responses.
    Waters L; Nelson M; Mandalia S; Bower M; Powles T; Gazzard B; Stebbing J
    Clin Infect Dis; 2008 Jan; 46(1):96-100. PubMed ID: 18171220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
    Balduin M; Sierra S; Däumer MP; Rockstroh JK; Oette M; Fätkenheuer G; Kupfer B; Beerenwinkel N; Hoffmann D; Selbig J; Pfister HJ; Kaiser R
    J Clin Virol; 2005 Dec; 34(4):277-87. PubMed ID: 16191482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy in AIDS patients with tuberculosis.
    Moreno S; Hernández B; Dronda F
    AIDS Rev; 2006; 8(3):115-24. PubMed ID: 17078482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-five years of AIDS: where are we now?
    Wainberg MA
    MedGenMed; 2006 Oct; 8(4):21. PubMed ID: 17415304
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in antiretroviral therapy.
    Taylor B; Olender S; Wilkin TJ; Hammer SM
    Top Antivir Med; 2011; 19(2):69-97. PubMed ID: 21868824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark.
    Bracher L; Valerius NH; Rosenfeldt V; Herlin T; Fisker N; Nielsen H; Obel N
    Scand J Infect Dis; 2007; 39(9):799-804. PubMed ID: 17701719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinically dangerous flaw in reporting statistical significance.
    Campillo C; Puigventos F; Riera M
    Clin Infect Dis; 2006 Apr; 42(8):1205-6; author repy 1206-7. PubMed ID: 16575745
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.
    Wynn GH; Zapor MJ; Smith BH; Wortmann G; Oesterheld JR; Armstrong SC; Cozza KL
    Psychosomatics; 2004; 45(3):262-70. PubMed ID: 15123854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.